Amersham, United Kingdom

Barry Edward Ayres

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Laboratories Limited. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barry Edward Ayres. Retrieved from https://idiyas.com/inventor/barry-edward-ayres

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Barry Edward Ayres: Innovator in Steroid Anaesthetics

Introduction

Barry Edward Ayres is a notable inventor based in Amersham, GB. He has made significant contributions to the field of anaesthetics, particularly through his innovative work on steroid anaesthetics.

Latest Patents

Ayres holds a patent for "Steroid anaesthetics of the pregnane and 19-norpregnane series." This patent describes compounds that possess a 3.alpha.-hydroxy group, a 5.alpha.-hydrogen atom or a 4,5-double bond, a 17.alpha.-hydrogen atom, a 20-oxo group, and at the 21-position, a hydrocarbon group that may be substituted by various functional groups. The patent also includes the acetals and 20-enol ethers of compounds having a 21-formyl group. He has 1 patent to his name.

Career Highlights

Ayres has worked with Glaxo Laboratories Limited, where he has been able to apply his expertise in the development of anaesthetic compounds. His work has contributed to advancements in medical science and patient care.

Collaborations

Throughout his career, Ayres has collaborated with notable colleagues, including Robin Lawrence and Leslie Stephenson. These collaborations have further enriched his research and development efforts.

Conclusion

Barry Edward Ayres is a distinguished inventor whose work in steroid anaesthetics has had a lasting impact on the field. His innovative contributions continue to influence medical practices today.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…